Dupilumab for Prevention of Recurrence of CRSwNP After ESS

Clinical trial NCT04596189 · COMPLETED

Trial details

NCT number: NCT04596189
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Rhinosinusitis With Nasal Polyps

Start date: 2021-05-25
Primary completion: 2024-04-23
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.